Categories AlphaGraphs, Earnings, Finance
Infographic: Highlights of Morgan Stanley (MS) Q4 2022 earnings report
Banking giant Morgan Stanley (NYSE: MS) on Tuesday reported lower earnings and revenues for the fourth quarter of 2022. The company’s stock dropped soon after the announcement.
Net income applicable to shareholders was $2.2 billion or $1.26 per share in the fourth quarter of 2022, compared to $3.7 billion or $2.01 per share in the same period a year ago. Adjusted earnings dropped to $1.31 per share from $2.08 per share last year.
The bottom line was hurt by a 12% decrease in revenues to $12.7 billion. The company delivered ROTCE of 12.6%.
Check this space to read management/analysts’ comments on Morgan Stanley’s Q4 2022 earnings
James Gorman, chief executive officer of Morgan Stanley, said, “we reported solid fourth-quarter results amidst a difficult market environment. Overall, 2022 was a strong year for the Firm as our clear strategy and balanced business model enabled us to deliver an ROTCE of 16% despite the complex macro backdrop.”
Prior Performance
_________________________________________________________________________________________________________________
Stocks you may like:
_________________________________________________________________________________________________________________
Most Popular
Paychex expected to report higher revenue and earnings for Q2 FY26
Paychex, Inc. (NASDAQ: PAYX), a leading provider of human capital management solutions, is undergoing an AI-driven transformation that enhances both its internal operations and client-facing services. Entering fiscal 2026, the
Signet Jewelers (SIG): A look at the progress made on Grow Brand Love
Shares of Signet Jewelers Limited (NYSE: SIG) fell over 3% on Tuesday. The stock has gained 3% year-to-date. The jewelry retailer delivered strong results for the third quarter of 2026,
Everything you need to know about Medline’s IPO
After a modest start to the year, IPO activity rebounded in the second half of the year as recession fears eased and investor confidence increased. Medical supply company Medline Inc.
